Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective

BACKGROUND: Ductal carcinoma in situ (DCIS) is an established precursor to invasive ductal carcinoma (IDC) and its coexistence with IDC appear to favor reduced biological aggressiveness. Its prognostic implication and ability to affect clinical outcome has been understudied in Asia. This study aims...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wai Peng, Shetty, Spoorthi Sudhakar, Seah, Chin Mui Jaime, Tan, Pei Ting, Tan, Su Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458486/
https://www.ncbi.nlm.nih.gov/pubmed/35892151
http://dx.doi.org/10.1002/cnr2.1646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458486/
https://www.ncbi.nlm.nih.gov/pubmed/35892151
http://dx.doi.org/10.1002/cnr2.1646

Ejemplares similares